Close Menu

NEW YORK – The Pancreatic Cancer Action Network (PanCAN) has launched an adaptive clinical trial platform, called Precision Promise, that allows investigators to evaluate more than one experimental therapy at the same time.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.